Literature DB >> 3945764

Use of the activated coagulation time as a measure of anticoagulation during interventional procedures.

J A Scott, A Berenstein, D Blumenthal.   

Abstract

The activated coagulation time (ACT) is a reliable method of determining the degree of anticoagulation caused by the administration of heparinized saline solutions during long interventional procedures. An automated system that simplifies the determination of the ACT is available and has proved useful in preventing hemostatic complications.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945764     DOI: 10.1148/radiology.158.3.3945764

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

1.  Activated clotting time or activated partial thromboplastin time as the method of choice for patients undergoing neuroradiological intervention.

Authors:  R Kubalek; A Berlis; M Schwab; J Klisch; M Schumacher
Journal:  Neuroradiology       Date:  2003-03-28       Impact factor: 2.804

Review 2.  Interventional radiology of the extracranial head and neck.

Authors:  N J Kagetsu; A Berenstein; I S Choi
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Nov-Dec       Impact factor: 2.740

3.  Pulmonary venous atrial obstruction after the Senning procedure: relief by catheter balloon dilatation.

Authors:  J D Coulson; R B Jennings; D H Johnson
Journal:  Br Heart J       Date:  1990-08

Review 4.  Use of the activated clotting time in anticoagulation monitoring of intravascular procedures.

Authors:  J Bowers; J J Ferguson
Journal:  Tex Heart Inst J       Date:  1993

5.  Two Cases of Hemorrhage in Benign Brain Tumors during Systemic Heparinization. Case Reports.

Authors:  T Nakagawa; S Onozuka; K Mayanagi
Journal:  Interv Neuroradiol       Date:  2001-07-15       Impact factor: 1.610

Review 6.  The Use of Heparin during Endovascular Peripheral Arterial Interventions: A Synopsis.

Authors:  Arno M Wiersema; Christopher Watts; Alexandra C Durran; Michel M P J Reijnen; Otto M van Delden; Frans L Moll; Jan Albert Vos
Journal:  Scientifica (Cairo)       Date:  2016-04-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.